SynthesisThoracic cancer2022

Efficacy and safety of bevacizumab combined with EGFR-TKIs in advanced non-small cell lung cancer: A meta-analysis.

Yifan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.